CHKB and pancreatic neoplasm: There was little or no contribution from Chk-α, Chk-β, or Etnk-2.59 Downregulation of Etnk-1 with siRNA significantly reduced cell viability, suggesting that Etnk-1 may be a potential therapeutic target in breast and pancreatic cancers.59